Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

: PICO: Intensive versus standard blood-pressure control for major adverse cardiovascular events in adults at increased cardiovascular risk

Page standards status: Informative

Raw xml | Download


<Group xmlns="http://hl7.org/fhir">
  <id value="588218"/>
  <meta>
    <versionId value="7"/>
    <lastUpdated value="2026-08-15T16:32:10.010Z"/>
    <profile
             value="http://hl7.org/fhir/uv/ebm/StructureDefinition/pico-specification"/>
  </meta>
  <language value="en"/>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml">
  <table class="narrative-table">
    <tbody>
<tr>


<th colspan="2" scope="row" class="row-header"><a name="metadata"> </a>Metadata</th>


</tr>

<tr>


<th scope="row" class="row-header">Title</th>



<td class="content-container">PICO: Intensive versus standard blood-pressure control for major adverse cardiovascular events in adults at increased cardiovascular risk</td>


</tr>













  
<tr>


<th scope="row" class="row-header">Identifier</th>



<td class="content-container">588218</td>


</tr>


  
<tr>


<th scope="row" class="row-header">Identifier</th>



<td class="content-container">PICO-2026-0142</td>


</tr>





























<tr>


<th scope="row" class="row-header">Steward (Publisher)</th>



<td class="content-container">Computable Publishing LLC</td>


</tr>











<tr>


<th scope="row" class="row-header">Description</th>



<td class="content-container"><div><p>This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p>
</div></td>


</tr>



<tr>


<th scope="row" class="row-header">Copyright</th>



<td class="content-container"><div><p>Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).</p>
</div></td>


</tr>


























































































<tr>
  <th colspan="2" scope="row" class="row-header">Generated using version 0.5.6 of the sample-content-ig Liquid templates</th>
</tr>

    </tbody>
  </table>
</div>
  </text>
  <extension url="http://hl7.org/fhir/StructureDefinition/artifact-author">
    <valueContactDetail>
      <name value="Khalid Shahin"/>
    </valueContactDetail>
  </extension>
  <extension
             url="http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-recorder">
    <valueContactDetail>
      <name value="Khalid Shahin"/>
    </valueContactDetail>
  </extension>
  <extension url="http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as">
    <valueMarkdown
                   value="PICO: Intensive versus standard blood-pressure control for major adverse cardiovascular events in adults at increased cardiovascular risk [Database Entry: FHIR Group Resource]. Contributors: Khalid Shahin [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 588218. Revised 2026-08-15. Available at: https://fevir.net/resources/Group/588218. Computable resource at: https://fevir.net/resources/Group/588218#json."/>
  </extension>
  <extension
             url="http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status">
    <valueCodeableConcept>
      <coding>
        <system
                value="http://terminology.hl7.org/CodeSystem/cited-artifact-status-type"/>
        <code value="active"/>
        <display value="Active"/>
      </coding>
    </valueCodeableConcept>
  </extension>
  <url value="https://fevir.net/resources/Group/588218"/>
  <identifier>
    <type>
      <coding>
        <system value="http://terminology.hl7.org/CodeSystem/v2-0203"/>
        <code value="ACSN"/>
        <display value="Accession ID"/>
      </coding>
      <text value="FEvIR Object Identifier"/>
    </type>
    <system value="https://fevir.net/FOI"/>
    <value value="588218"/>
    <assigner>
      <display value="Computable Publishing LLC"/>
    </assigner>
  </identifier>
  <identifier>
    <use value="official"/>
    <system value="http://example.org/fhir/sid/pico-register"/>
    <value value="PICO-2026-0142"/>
  </identifier>
  <title
         value="PICO: Intensive versus standard blood-pressure control for major adverse cardiovascular events in adults at increased cardiovascular risk"/>
  <status value="active"/>
  <publisher value="Computable Publishing LLC"/>
  <contact>
    <telecom>
      <system value="email"/>
      <value value="support@computablepublishing.com"/>
    </telecom>
  </contact>
  <description
               value="This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide."/>
  <copyright
             value="Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse)."/>
  <membership value="conceptual"/>
  <combinationMethod value="all-of"/>
  <characteristic>
    <code>
      <coding>
        <system value="https://fevir.net/resources/CodeSystem/179423"/>
        <code value="population"/>
        <display value="Population"/>
      </coding>
    </code>
    <valueCodeableConcept>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="38341003"/>
        <display value="Hypertensive disorder, systemic arterial"/>
      </coding>
      <text
            value="Hypertension with systolic blood pressure 130-180 mmHg and at least one additional cardiovascular risk factor"/>
    </valueCodeableConcept>
    <exclude value="false"/>
    <description
                 value="Adults with a measured systolic blood pressure between 130 and 180 mmHg inclusive, together with at least one of: clinical or subclinical cardiovascular disease, chronic kidney disease with eGFR 20-59 mL/min/1.73 m2, a 10-year Framingham risk score of 15 percent or greater, or age 75 years or older."/>
  </characteristic>
  <characteristic>
    <code>
      <coding>
        <system
                value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
        <code value="age"/>
        <display value="Age Range"/>
      </coding>
    </code>
    <valueRange>
      <low>
        <value value="50"/>
        <unit value="years"/>
        <system value="http://unitsofmeasure.org"/>
        <code value="a"/>
      </low>
    </valueRange>
    <exclude value="false"/>
    <description
                 value="Aged 50 years or older at the time of eligibility assessment. No upper age limit is applied."/>
  </characteristic>
  <characteristic>
    <code>
      <coding>
        <system value="https://fevir.net/resources/CodeSystem/179423"/>
        <code value="intervention"/>
        <display value="Intervention"/>
      </coding>
    </code>
    <valueCodeableConcept>
      <text
            value="Intensive blood-pressure control: antihypertensive therapy titrated to a systolic target below 120 mmHg"/>
    </valueCodeableConcept>
    <exclude value="false"/>
    <description
                 value="Any antihypertensive regimen titrated at monthly intervals to achieve and maintain a systolic blood pressure below 120 mmHg. The specific agents used are not constrained by this question."/>
  </characteristic>
  <characteristic>
    <code>
      <coding>
        <system value="https://fevir.net/resources/CodeSystem/179423"/>
        <code value="comparator"/>
        <display value="Comparator"/>
      </coding>
    </code>
    <valueCodeableConcept>
      <text
            value="Standard blood-pressure control: antihypertensive therapy titrated to a systolic target below 140 mmHg"/>
    </valueCodeableConcept>
    <exclude value="false"/>
    <description
                 value="Any antihypertensive regimen titrated to achieve and maintain a systolic blood pressure below 140 mmHg, reflecting the guideline-recommended target in force at the time the question was formulated."/>
  </characteristic>
  <characteristic>
    <code>
      <coding>
        <system value="https://fevir.net/resources/CodeSystem/179423"/>
        <code value="outcome-measure"/>
        <display value="Outcome Measure"/>
      </coding>
    </code>
    <valueCodeableConcept>
      <text
            value="Major adverse cardiovascular events: composite of myocardial infarction, other acute coronary syndrome, stroke, acute decompensated heart failure, or death from cardiovascular causes"/>
    </valueCodeableConcept>
    <exclude value="false"/>
    <description
                 value="Time to first occurrence of any component of the composite, adjudicated by a committee unaware of treatment assignment. Individual components are reported as separate outcome measures in the evidence report."/>
    <relativeTime>
      <offsetDuration>
        <value value="5"/>
        <unit value="years"/>
        <system value="http://unitsofmeasure.org"/>
        <code value="a"/>
      </offsetDuration>
    </relativeTime>
  </characteristic>
</Group>